StockStory.org on MSN
Bristol-Myers Squibb (NYSE:BMY) Reports Bullish Q3
Biopharmaceutical company Bristol Myers Squibb (NYSE:BMY) reported in Q3 CY2025, with sales up 2.8% year on year to $12.22 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback